Mannose-Binding Lectin Deficiency and Ischemic Stroke Outcomes
Author Information
Author(s): Osthoff Michael, Katan Mira, Fluri Felix, Schuetz Philipp, Bingisser Roland, Kappos Ludwig, Steck Andreas J., Engelter Stefan T., Mueller Beat, Christ-Crain Mirjam, Trendelenburg Marten
Primary Institution: University Hospital Basel, Basel, Switzerland
Hypothesis
Is there an association between Mannose-Binding Lectin deficiency and infarction size and functional outcomes in ischemic stroke patients?
Conclusion
Mannose-Binding Lectin deficiency is linked to smaller cerebral infarcts and better outcomes in patients receiving conservative treatment for ischemic stroke.
Supporting Evidence
- Patients with MBL deficiency had lower median MBL levels and better outcomes.
- MBL deficient patients showed significantly smaller infarction sizes.
- The study suggests MBL plays a role in the pathophysiology of cerebral injury.
Takeaway
If you have low levels of a protein called Mannose-Binding Lectin, you might have smaller strokes and recover better after a stroke.
Methodology
The study analyzed MBL levels in 353 patients with acute ischemic stroke, comparing outcomes based on treatment type and MBL levels.
Potential Biases
Potential bias due to the post hoc analysis and lack of MBL2 genotyping.
Limitations
The study's small sample size in the thrombolysis group limits the significance of the findings.
Participant Demographics
Median age of participants was 75 years, with a mix of treatment types (287 conservative, 66 thrombolysis).
Statistical Information
P-Value
p=0.025
Confidence Interval
95% CI 1.02–1.48
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website